Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorHemoCept Inc.
About this trial
The objective of this observational pilot study is to collect HemoCept device data from subjects undergoing diagnostic right heart catheterization (RHC) procedures.
Eligibility criteria
Qualifiers
Subjects or representatives must have voluntarily signed the informed consent form before any study related procedures.
Subjects can be any gender but must be age 18 or older.
Subject is able and willing to provide informed consent and HIPAA authorization.
Subject is able and willing to meet all study requirements.
Disqualifiers
Subject is pregnant, breastfeeding, or intends to become pregnant during this study.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Locations
1Boulder Heart80303, BoulderColorado, United States
Sponsors and collaborators
HemoCept Inc.
Lead sponsor
Source ClinicalTrials.gov